Target-focused macrocycle discovery

AI-Guided De Novo
Cyclic Peptide Design Service

Start with your target. Build diverse macrocyclic peptide candidates for synthesis and experimental testing.

CD ComputaBio combines AI-guided molecular design, structural analysis and chemistry review to develop new peptide starting points for your discovery program.

Target-defined designStructural diversityExperiment-ready candidates
Cyclic peptide molecular illustration
Home / Peptide Drug Design & Development / De Novo Cyclic Peptide Design

A new starting point for your target

When Your Target Needs a New Peptide Ligand

De novo cyclic peptide design creates new peptide sequences and constrained backbones around a defined molecular objective. A known peptide lead is not required. The aim is to propose chemically defined candidates whose predicted structures and target interactions justify a first experimental campaign.

As part of our peptide drug design and development services, this service supports target-binding macrocycles for therapeutic discovery, targeted delivery and research. The design brief sets the required binding site, functional objective, selectivity profile and downstream use before candidate generation begins.

01

A Target Without a Peptide Lead

Begin with a protein target and a biological question. We assess available structural information and identify a suitable design region before generating first-generation candidates.

02

A Defined Interface or Binding Site

Use a known epitope, interaction hotspot, partner interface or competing ligand to guide where the macrocycle should bind and which interactions it should reproduce.

03

A Ligand for a New Modality

Discover a targeting peptide for a conjugate, imaging probe or radioligand program. Potential attachment positions and the intended assay format enter the initial design constraints.

Already have a peptide sequence and activity data? Share the existing series so we can scope focused redesign and optimization within the same project discussion.

First, understand the binding opportunity

Define Where the Peptide Should Bind

A useful design campaign starts with a biologically relevant target model. We review the protein construct, domain boundaries, oligomeric state and structural coverage, then examine the accessibility and shape of the proposed interface.

Experimental structures, predicted models and known complexes provide different levels of support. Flexible loops, unresolved regions, glycans and membrane proximity can change whether a modeled surface is accessible in the assay or native setting.

When only a sequence is available, structure prediction and confidence assessment establish whether the design region is sufficiently supported. Alternative constructs or additional structural information may be recommended before a large campaign.

Share a target and preferred binding region →

Co-design the complete molecule

Backbone, Sequence and Cyclization

Ring topology determines which conformations a peptide can access. Sequence design and closure chemistry are evaluated together to build candidates suited to the target surface and subsequent synthesis.

A / BACKBONE

Target-Conditioned Backbone Design

Generate or sample constrained backbones around the selected site, exploring ring size, backbone geometry and hotspot placement. Diverse starting geometries help test more than one binding hypothesis.

Output: representative backbone families and proposed binding orientations.

B / INTERFACE

Sequence and Contact Design

Select residues that complement the local surface through shape, hydrogen bonding, electrostatics and hydrophobic contacts. Evaluate intramolecular packing alongside the peptide–protein interface.

Output: candidate sequences with annotated contact hypotheses.

C / CLOSURE

Cyclization Strategy Selection

Consider head-to-tail or side-chain closure and suitable linkage chemistries. Review closure geometry, ring strain, residue availability and protecting-group requirements with the planned synthetic route.

Output: a defined connectivity map and closure strategy for each candidate.

D / CHEMISTRY

Chemical Diversity Expansion

Evaluate D-amino acids, noncanonical side chains and selected backbone modifications where structural methods and synthesis support them. Expansion can be staged after an initial conventional design series.

Output: chemically specified variants with clear stereochemistry and modification sites.

Cyclic peptide architecture informed by SFTI-1 (PDB 1JBL).3

Diversity with a purpose

Build a Candidate Set That Tests Different Ideas

A first synthesis set should capture meaningful differences in backbone shape, sequence and contact pattern. Closely related variants can probe a specific interaction; structurally distinct candidates explore alternative solutions.

For programs that need a broader experimental search, our peptide library design services can help define a complementary library strategy. A computational candidate set and a display library require different construction and testing plans.

From generated structures to a synthesis decision

Prioritize Across Binding, Diversity and Feasibility

Candidate ranking combines complementary evidence. Structure prediction, interface analysis and selected physics-based calculations address different questions; together they help identify a balanced first batch and explain why each molecule is included.

AssessmentWhat We ExamineHow It Supports Selection
Binding geometrySurface complementarity, hotspot contacts, clashes and exposed hydrophobic patches.Retain plausible interaction hypotheses for experimental testing.
Conformational supportAgreement between design and independent predictions, structural confidence and alternative conformations.Identify candidates more likely to support the intended binding geometry.
Dynamic behaviorConformational sampling and complex simulations for selected candidates.Investigate flexibility and contact persistence under the chosen simulation conditions.
Selectivity hypothesesDifferences at the intended site across selected homologs or counter-targets.Prioritize discriminating interactions and plan the relevant counterscreens.
Developability signalsCharge, hydrophobicity, potential aggregation and accessible proteolytic liabilities.Balance predicted binding with practical handling and follow-up requirements.
Chemistry and diversityBuilding blocks, connectivity, ring closure, purification risk and structural clustering.Choose a synthetically practical set that spans distinct design hypotheses.

Computational scores support relative prioritization. Binding affinity, selectivity and biological activity are established through the corresponding experiments.

Make the next experiment count

Connect Designs with Synthesis and Testing

Computational delivery can stand alone or continue into an agreed experimental scope. Chemistry review is incorporated before committing to synthesis, with test conditions, controls and decision criteria defined around the intended use.

01 / MAKE

Synthesize and Characterize

Prepare selected macrocycles, introduce agreed modifications and purify material for testing. HPLC and LC-MS support purity and mass assessment; connectivity, stereochemistry or conformation questions may require additional methods.

Decision: which candidates meet the agreed identity, purity and handling requirements?

02 / TEST

Confirm Binding and Function

Use suitable biophysical assays such as SPR or BLI to assess binding. Competition, homolog counterscreens and cell-based studies can then address site engagement, selectivity and the intended biological effect.

Decision: which molecules warrant confirmation, functional characterization or optimization?

03 / LEARN

Use Results to Guide Redesign

Map positive and negative results back to the structural hypotheses. Examine whether sequence changes, ring topology or assay behavior explain the observations, then propose a focused analog series.

Decision: refine the current family, investigate a different binding pose or explore a new scaffold?

Plan for the Intended Exposure and Modality

After binding confirmation, peptide developability assessment can guide stability and property studies. Conjugate projects additionally examine whether attachment preserves binding and supports the required uptake or retention profile.

Scope Design + Validation ↗

A reviewable molecular design package

Know What You Will Receive

Deliverables are matched to the selected computational and experimental scope. Candidate numbers, synthesis quantities, analytical specifications, assay formats and iteration rounds are defined in the project proposal.

✓

Target and Site Assessment

Prepared target models, structural assumptions, selected design regions and the rationale connecting the proposed site to the biological objective.

✓

Chemically Defined Candidates

Sequences, residue stereochemistry, noncanonical building blocks, modification positions and explicit cyclization connectivity for each nominated molecule.

✓

Structural Models

Candidate and target-complex coordinates, representative poses and interface annotations, with file formats selected to preserve the relevant chemistry.

✓

Prioritized Candidate Matrix

Assessment criteria, structural family assignments, synthesis considerations and a transparent explanation of the proposed first experimental set.

✓

Experimental Data, When Included

Agreed analytical and assay results, sample identifiers, controls, conditions and interpretation linked to the corresponding design version.

✓

Next-Round Recommendations

A concise technical report with method and parameter records, conclusions supported by the available evidence and recommended analogs or validation steps.

Flexible engagement:Computational DesignDesign + SynthesisDesign–Make–Test Iteration

Design around the downstream use

Starting Points for Therapeutic
and Targeting Programs

The required biology shapes both the candidate design and the evidence needed to advance it.

Receptor and Extracellular Protein Ligands

Design candidates for accessible receptor domains, enzymes or soluble proteins. Binding confirmation can be followed by ligand competition and functional assays suited to the mechanism.

Protein–Protein Interaction Modulators

Explore macrocycles at selected interaction hotspots. Competition and pathway assays test whether binding translates into modulation; intracellular applications also require evidence of cellular access and engagement.

PDC and Radioligand Targeting Heads

Seek ligands that tolerate attachment at suitable positions. Follow-up evaluates conjugated binding, target-dependent uptake or retention, and properties relevant to the intended payload.

Research Probes and Competitive Binders

Develop molecular starting points for target interrogation and assay development. Labels or handles are introduced at positions chosen to preserve the binding hypothesis.

Pursuing oral exposure? Explore our oral cyclic peptide design program for absorption-focused design, permeability assessment and oral development planning.

Scientific foundation

From Generative Models to Testable Macrocycles

Published work on RFpeptides describes a target-directed pipeline connecting backbone generation, sequence design and cyclic peptide–protein complex prediction, followed by experimental testing.1 AfCycDesign research also demonstrates cyclic peptide structure prediction and sequence-design approaches.2

These advances support structure-guided exploration of macrocycle space. Project methods are selected according to target information, chemical representation, validation needs and applicable software terms.

Project questions

Frequently Asked Questions

Can you start without a known peptide binder?

Yes. De novo design begins with the target and binding objective. Feasibility depends on structural support for the chosen site and a suitable experimental route to test the resulting candidates.

What if only the protein sequence is available?

We first assess predicted structures and local confidence around potential design regions. Flexible or poorly resolved sites may require a revised construct, a different region or additional experimental information.

Can I specify a binding site or competing ligand?

Yes. Structural complexes, mutagenesis data, epitope information and competitor-binding results can define constraints. These inputs help connect the intended pose to a meaningful competition or functional assay.

Can designs contain non-natural amino acids?

Selected noncanonical residues and modifications can be evaluated where modeling and synthesis support their chemistry. The proposal specifies which chemical features are explored in the initial design and which are introduced during follow-up optimization.

How are candidates and timelines defined?

The scope reflects target preparation, design complexity, chemical diversity and the planned experiments. We agree on computational nominations, synthesis batches and review points before work begins; synthesis and validation schedules are planned separately.

Can the project continue into conjugation or optimization?

Yes. Confirmed binders can enter analog design, stability optimization or conjugation studies. Ownership, confidentiality, data use and the scope of follow-up work are documented in the project agreement.

Your next design campaign starts here

Bring Your Target.
Define Your First Candidate Set.

Share the target, available structures, desired biological effect and whether you need computational design, synthesis or experimental validation. We will provide initial project feedback within 24 hours.

For structure files or supporting data, email contact@computabio.com.

References

  1. Rettie, S. A. et al. Accurate de novo design of high-affinity protein-binding macrocycles using deep learning. Nature Chemical Biology 21, 1948–1956 (2025). doi:10.1038/s41589-025-01929-w.
  2. Cyclic peptide structure prediction and design using AlphaFold2. Nature Communications (2025). doi:10.1038/s41467-025-59940-7.
  3. Korsinczky, M. L. J. et al. Solution structures by 1H NMR of the novel cyclic trypsin inhibitor SFTI-1 from sunflower seeds and an acyclic permutant. Journal of Molecular Biology 311, 579–591 (2001). Structure record: PDB 1JBL.

For Research Use Only.

Online Inquiry

Submit your project details below, and our team will respond within 24 hours.

x
Need help getting the data you need?

Talk to our technical team about your project!

I Want To Talk